Does Ozempic Burn Fat or Just Reduce Appetite? A New Study Offers a Clue

• Scientists are starting to unravel the secrets behind Ozempic/Wegovy and similar GLP-1 drugs.
• New trial data shows GLP-1 therapy can boost the body’s fat-burning potential, not just reduce appetite.
• The study, conducted in Ireland, involved 30 patients with obesity and obstructive sleep apnea.
• Results indicated that people on liraglutide experienced a significant increase in their ability to burn off visceral fat.
• Researchers emphasize the need for more studies to confirm these findings and explore newer, more effective GLP-1 drugs.

Source: Gizmodo